BioSig Technologies announces FDA 510(k) clearance for PURE EP system
BioSig announced it has received 510(k) clearance for its first product, PURE EP System, from the FDA. The non-invasive system is intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic signals. August 14, 2018